1st Annual Pennington Cancer Institute Cancer Conference


Cancer screening, early detection, and treatment are rapidly changing, with new technologies and therapies being introduced. This year almost 2 million Americans will be diagnosed with cancer. Therefore, it is critical for primary care providers to remain current with guidelines. Understanding the initial cancer therapy is also essential for optimal patient care, as patients often seek information from multiple sources, including their primary providers. This conference will address numerous topics related to common forms of cancer commonly seen and often diagnosed by PCPs.

Learning Objectives

Following the completion of this activity, participants should be able to:

  • Discuss the capabilities of the PCI to raise awareness of the scope of cancer services available and how best to access and use them
  • Provide classification of high-risk individuals for various screening efforts to detect cancer early
  • Apply the latest standards for the treatment of early-stage breast, colorectal, and lung cancer
  • Experience the workings of tumor boards as panels of cancer experts conduct discussions of real patients to reach a multidisciplinary treatment plan consensus

Who Should Attend

Physicians, Nurses, Physician Assistants, Medical Researchers, and Pharmacists

Registration is Closed

This is an in-person CME event

The registration fee is $75 and includes continental breakfast, lunch, networking reception, and CME credit.

The early registration deadline is April 7, 2023. After April 7, 2023, registration increases to $100.

The conference registration deadline is Wednesday, April 14, 2023. Register early, as space is limited.

Discounted registration is available for UNR Med Faculty, Medical Students and Residents. For additional information, please call (775) 784-8078 or sultanak@med.unr.edu.

Cancellation Policy

Cancellations received by April 14, 2023 will receive a full refund less a $25 cancellation fee. Cancellations after April 14, 2023 are non-refundable.

Program Support

This program is supported by William N. Pennington Cancer Institute.

The contents are those of the author(s) and do not necessarily represent the official views of Renown Health.